Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

1(33.3%)

Phase 3

1(33.3%)

N/A

1(33.3%)

3Total

Phase 2(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07305103Active Not Recruiting

Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning

Role: collaborator

NCT04171674Not ApplicableCompleted

Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.

Role: collaborator

NCT05099939Recruiting

Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis

Role: collaborator

NCT04617756Phase 2Recruiting

Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract

Role: collaborator

NCT03381950Active Not Recruiting

Chronic Kidney Disease - Renal Epidemiology and Information Network

Role: collaborator

NCT04102332Completed

Safe Infusion Device in Reducing Occupational Exposure of Nurses

Role: collaborator

NCT03004651Completed

BMI and Ultrasound/Clinical Assessments of RA Disease Activity

Role: collaborator

NCT02841111Completed

Old Red Blood Cell In Renal Transplantation

Role: collaborator

NCT00002884Phase 3Unknown

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Role: lead

All 9 trials loaded